Operating Margin: Qiagen (QGEN)

Symbol and logo of brand qiagen.com (QGEN)

Is it worth investing in Qiagen N.V. (QGEN), given its flawless image as a global leader in molecular diagnostics? Stability is confirmed by the moderate influence of contractors, as chemistry is produced in-house. An analysis of operating profitability via EBIT reveals a margin of safety, where the parameter has stabilized at 25.20. The business's resilience is guaranteed by a "razor-blade" model that locks customers into proprietary consumables.

qiagen.com (QGEN): Return on Sales by Operating Profit from 07/04/2022 to 11/20/2026

Analytical breakdowns for Qiagen N.V. (QGEN)

- share price and consensus valuation forecast:
- company stock exchange capitalization indicators:
Basic company analysis:QGEN, Qiagen NV
Core merchandise of Qiagen Corp

To objectively assess the efficiency of Qiagen N.V. (QGEN), it is critical for a manager to understand the operating profit margin before interest and taxes. An EBIT margin analysis reveals the business's ability to generate cash flow from core operations, which for Qiagen N.V. is driven by the high margins of exclusive consumables for its installed base of analyzers.

Competitors of Qiagen N.V. (QGEN)

Operating Sales Margin TEM|Operating Sales Margin Ionis Pharma (IONS)|Operating Profitability Repligen Corp (RGEN)|RNA - Operating Return on Sales|crisprtx.com - Operating Sales Margin|Operating Profit Rate WGS|RARE - Operating Profitability|Beam Tx (BEAM) - Operating Sales Margin|SRPT (Sarepta Therapeutics Inc) - Operating Sales Margin|TWST: Operating Profit Ratio|TXG (10xgenomics.com) - Operating Margin|NTLA (Intellia Therapeutics, Inc.) - Operating Profit Ratio|Operating Profitability Stoke Corp (STOK)|Profitability of Operations BioLife|Operating Margin WVE (Wave Life Sciences Ltd)|MAZE: Return on Sales by Operating Profit|Sionna Therapeutics, Inc. - Operating Margin|Operating Profit Rate PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Operating Sales Margin|QURE - Profitability of Operations|MGTX (MeiraGTx Corp) - Operating Margin|Operating Return on Sales REGENXBIO Inc. RGNX|Operating Profitability Solid Biosciences (SLDB)|Ocugen Corp - Return on Sales by Operating Profit|Operating Profitability Pacific Biosciences PACB|Operating Profit Ratio BNTC (Benitec)|Design Corp - Operating Margin|Rocket Pharmaceuticals - Operating Profit Ratio|Return on Sales by Operating Profit 4D Molecular Therapeutics, Inc.|Operating Return on Sales Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operating Margin|Operating Return on Sales Editas EDIT|Operating Margin SLN|ProQR Therapeutics - Return on Sales by Operating Profit|Operating Margin CDXS (Codexis, Inc.)|SGMO: Return on Sales by Operating Profit|Nautilus Biotechnology - Operating Margin|Operating Profit Rate MGX (Metagenomi, Inc)|DTIL: Operating Margin|GBIO: Operating Profit Ratio|Operating Profitability Boundless Bio Inc.|Operating Sales Margin Exicure (XCUR)|Operating Margin IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operating Profit Rate|Mustang Bio, Inc. - Operating Sales Margin|RNAZ - Operating Sales Margin|BNGO: Operating Sales Margin|APDN (Applied DNA Sciences Inc) - Return on Sales by Operating Profit|BLUE (Bluebird Bio) - Operating Sales Margin|ImmunoPrecise Antibodies Ltd - Operating Profit Rate|OMGA (Omega Therapeutics Inc) - Operating Margin|Operating Profitability OMIC|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability